Mirvaso Prices, Coupons and Patient Assistance Programs
Mirvaso (brimonidine topical) is a member of the topical anti-rosacea agents drug class and is commonly used for Rosacea.
This Mirvaso price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies. The cost for Mirvaso topical gel 0.33% is around $426 for a supply of 30 grams, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.
Mirvaso is available as a brand name drug only, a generic version is not yet available. For more information, read about generic Mirvaso availability.
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount CardPrint Now
The free Drugs.com Discount Card can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Please note: This is a drug discount program, not an insurance plan.
Manufacturer Coupons and Rebates
Mirvaso offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.
Mirvaso Cost Reduction Card: Insured Patients without coverage for mirvaso may pay no more than $80 on each prescription; for additional information contact the program at 855-820-3228.
|Number of uses:||Per prescription until program expires|
Patient Assistance Programs for Mirvaso
Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.
Provider: Galderma Patient Assistance Program
- Must have no prescription insurance, be ineligible for any state and federal programs
- At or below 200% of FPL
- Medically appropriate condition/diagnosis
- The patient must also be a US citizen being treated by a US doctor.
- Mirvaso (brimonidine) Gel; Topical